Abstract
Emergency authorized coronavirus disease 2019 (COVID-19)-neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons learned.
Author supplied keywords
Cite
CITATION STYLE
Bariola, J. R., McCreary, E. K., Khadem, T., Snyder, G. M., Wadas, R. J., Nace, D. A., … Schmidhofer, M. (2021). Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy across a Large Health System during a Global Pandemic. Open Forum Infectious Diseases, 8(7). https://doi.org/10.1093/ofid/ofab151
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.